NEW YORK, N.Y., Dec. 2, 2015 (SEND2PRESS NEWSWIRE) — Philosys, the maker of Gmate(R) products, announced today that the U.S. Food and Drug Administration (FDA) has approved clearance for the Gmate SMART Blood Glucose Monitoring System and App for Android(TM). The Gmate SMART is a small, portable blood glucose meter that plugs into the headphone […]
ORLANDO, Fla., Nov. 17, 2015 (SEND2PRESS NEWSWIRE) — MEDITE Cancer Diagnostics, Inc. (OTCQB:MDIT, the ‘Company’ / OTCMKTS:MDIT) specializing in the development, manufacturing, and marketing of molecular biomarkers and premium medical devices for detection, risk assessment and diagnosis of cancer and precancerous conditions announces its third quarter and nine month 2015 results.
NEW YORK, N.Y., Oct. 15, 2015 (SEND2PRESS NEWSWIRE) — Nationally known personal injury and mass tort law firm Weitz and Luxenberg, P.C., today announced that one of its lead attorneys, Paul J. Pennock, successfully argued to a federal court judicial panel to consolidate into a single multidistrict litigation dozens of lawsuits claiming injuries from use […]
ORLANDO, Fla., Aug. 27, 2015 (SEND2PRESS NEWSWIRE) — MEDITE Cancer Diagnostics, Inc., (OTC/QB: MDIT) specializing in the development, manufacturing, and marketing of molecular biomarkers and premium medical devices for detection, risk assessment and diagnosis of cancer and precancerous conditions announces its Mexican distributor, ATYDE won a public tender for delivery of 31 MEDITE tissue staining […]
ORLANDO, Fla., Aug. 17, 2015 (SEND2PRESS NEWSWIRE) — MEDITE Cancer Diagnostics, Inc. (‘Company,’ OTCQB symbol: MDIT / OTCBB:MDIT), specializing in the development, manufacturing, and marketing of molecular biomarkers and premium medical devices for detection, risk assessment and diagnosis of cancer and precancerous conditions announces second quarter and six month 2015 results.
NEW YORK, N.Y., Aug. 12, 2015 (SEND2PRESS NEWSWIRE) — Weitz and Luxenberg, P.C., today launched an investigation into injuries sustained by patients when catheters used during cardiac angiogram procedures to inject contrast dye into blood vessels malfunctioned by either splitting or separating, the firm announced.
NEW YORK, N.Y., June 15, 2015 (SEND2PRESS NEWSWIRE) — Nationally prominent personal injury law firm Weitz and Luxenberg, P.C., today said that 95 percent of registered eligible patients are now enrolled in the Stryker modular hip settlement program. This program has been established to ensure that each injured patient will receive a share of more […]
ORLANDO, Fla., May 14, 2015 (SEND2PRESS NEWSWIRE) — MEDITE Cancer Diagnostics, Inc. (‘Company,’ OTCQB symbol: ‘MDIT’ / OTCBB:MDIT), specializing in the development, manufacturing and marketing of molecular biomarkers and premium medical devices for detection, risk assessment and diagnosis of cancer and precancerous conditions, announces change of auditors.
NEW YORK, N.Y., April 9, 2015 (SEND2PRESS NEWSWIRE) — A recent voluntary recall of Zimmer Persona Knee Trabecular Metal Tibial Plates, which the U.S. Food and Drug Administration (FDA) subsequently categorized as a Class II recall, has led Weitz and Luxenberg, P.C., to begin accepting cases involving Zimmer Persona Knee replacement injuries, the law firm […]
SUGAR LAND, Texas, April 6, 2015 (SEND2PRESS NEWSWIRE) — TeDan Surgical Innovations (TSI) announced the release of the Phantom AL Retractor System used to facilitate minimally invasive exposure and retraction of the anterior lumbar spine. The Phantom AL Retractor System provides superior visualization with minimal tissue trauma during MIS ALIF procedures.
